Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Connect with us

Hi, what are you looking for?

slide 3 of 2
THE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & LifestyleTHE BIZNOB – Global Business & Financial News – A Business Journal – Focus On Business Leaders, Technology – Enterpeneurship – Finance – Economy – Politics & Lifestyle

Finance

Finance

Fitbit’s share value surged on Monday

fitbits
fitbits

Listen to the article now

Citron bets on Fitbit

Wearable technology company Fitbit saw its stock rise 15% on Monday after praise from short-seller Citron Research.

The firm, which recently forecasted Snapchat’s turnaround, reported that Fitbit’s stock price could increase by more than 200% in 2018. The analysts argue that their value stems from the health care initiatives that Fitbit offers. These programs include a glucose-monitoring partnership with DexCom Inc., an employee wellness partnership with UnitedHealthCare, and a cloud partnership with Google. They explain,

What was once a piñata for short sellers (since IPO) has transformed itself to one of the most under-appreciated med-tech stories in the market with a balance sheet and brand equity that gives investors a tremendous investing opportunity.

The report continues to argue that Fitbit will soon become the main wearable technology company not named Apple; indeed, they equate it to the Android of wearable tech. Citron analysts believe that health technology is due for a rebound and that Fitbit will reap the benefits of that.

Plus, Fitbit is currently succeeding. Although they have struggled in the past couple years, falling to 60% below its $20 IPO, the company’s stock is up 35% this month. This partially stems Fitbit’s announcement that they sold a million Versa smartwatches since April. The announcement overcame Apple’s watchOS updates at WWDC and news of the company’s CFO leaving. Additionally, the firm released the Fitbit Ace, their first kids’ device.

Fitbit’s future depends on the success of health technology, but if Citron’s predictions are correct, Fitbit could finally get back to their IPO value and maybe even eclipse that.

 

Featured image via Wikimedia Commons


Comment Template

You May Also Like

Technology

AMD achieved a major milestone in 2024, surpassing 100 million gaming chips shipped. Strong demand for Ryzen processors fueled growth, despite a decline in...

Business

AMD faces challenges in the AI chip race as its latest forecast failed to meet investor expectations, causing a stock decline. While the company...

Business

Palantir Technologies’ 2025 revenue outlook highlights its rapid growth as a leader in AI innovation. Projecting $3.75 billion in revenue, Palantir excels in both...

Health

New York Governor Kathy Hochul refuses to extradite Dr. Margaret Carpenter to Louisiana for prescribing abortion pills, sparking a legal showdown over state sovereignty...

Notice: The Biznob uses cookies to provide necessary website functionality, improve your experience and analyze our traffic. By using our website, you agree to our Privacy Policy and our Cookie Policy.

Ok